Ikonisys announces the results of its annual ordinary and extraordinary general meeting of June 28, 2023
Adoption of all the resolutions put to the vote
Paris, June 30, 2023 – 5:45 p.m. – Ikonisys SA (ISIN Code: FR00140048X2 / Mnemonic: ALIKO), a company specializing in the early and precise detection of cancer thanks to a unique and fully automated solution for medical diagnostic laboratories, announces that all resolutions presented to the ordinary annual and extraordinary general meeting held on June 28, 2023 (the “General Meeting”) were adopted by the shareholders, in accordance with the recommendations of the Board of Directors, and in particular the resolutions relating to the approval of the parent company and consolidated financial statements for the 2022 financial year and the financial delegations to the Board of Directors.